Depression
Blood test might predict how well a depressed patient responds to antidepressants
Published in Drug Week, January 6th, 2012
The method would involve a blood test for a protein called vascular endothelial growth factor (VEGF). A Loyola study found that among depressed patients who had higher than normal blood levels of VEGF, more than 85 percent experienced partial or complete relief from depression after taking escitalopram (brand name Lexapro®). By comparison, fewer than 10 percent of depressed patients who had low levels of VEGF responded to the drug.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2012-01-06)
More Articles from Drug Week
- Arthritis
Researchers from University of Gothenburg Describe Findings in Arthritis - Natural Product Chemistry
Researchers from University of Halle Report on Findings in Natural Product Chemistry - Nitrogen Oxides
Researchers from University of Illinois Detail New Studies and Findings in the Area of Nitrogen Oxides - Small Molecule Inhibitors
Researchers from University of Iowa Describe Findings in Small Molecule Inhibitors - Blood Pressure
Researchers from University of Iowa Report Details of New Studies and Findings in the Area of Blood Pressure - Heart Attack
Researchers from University of Leeds Provide Details of New Studies and Findings in the Area of Heart Attack - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
